Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Personalis Establishes UK Subsidiary and Appoints Mark Dronsfield as Director of European Sales

Published: Wednesday, September 25, 2013
Last Updated: Wednesday, September 25, 2013
Bookmark and Share
Personalis announced the formation of its UK subsidiary, Personalis UK Limited, to better serve the needs of customers across Europe.

The company also announced the appointment of Mark Dronsfield, Ph.D., as Director of European Sales.

“Given the expanding research and clinical demands for large scale exome and genome analysis, we felt it was important to augment our presence in the European markets,” said Personalis CEO John West.  “We wanted to be prepared to build infrastructure on both the commercial and operational sides, so we are best able to address the needs of researchers and clinicians.”

West continued, “We are especially pleased to open our UK subsidiary as two of our major investors, Abingworth Management LLP and Dr. Herman Hauser, FRS, are UK-based.” Both Abingworth and Dr. Hauser’s Amadeus venture fund were investors in Solexa, Ltd, inventor of the sequencing-by-synthesis technology at the core of Illumina’s sequencing systems today. Abingworth’s Dr. Jonathan MacQuitty currently serves as Personalis’ Chairman.

Initially, Personalis intends to build out its commercial team, but will also build services infrastructure in the UK as customers’ needs require.

Mark Dronsfield, Personalis’ newly appointed Director of European Sales, was most recently Head of Commercial Operations Europe for RainDance Technologies and has also held European commercial operations positions for Illumina, Affymetrix and Life Technologies.

“We believe that the combination of Personalis’ deep expertise in exome/genome sequencing and analysis, along with a direct presence in Europe, will open many new opportunities as the clinical demand for next generation sequencing rapidly grows,” said Dronsfield.  “I am really excited to be part of Personalis’ European expansion.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!